Law firms to receive almost $600,000 for work on Bentley impeachment

Taxpayers will pay a total of almost $600,000 in legal fees to two private law firms on opposite sides of the impeachment investigation of former Gov. Robert Bentley.

Last year, the House Judiciary Committee hired Jack Sharman of the Birmingham firm Lightfoot, Franklin & White to conduct the impeachment investigation. The Alabama Legislature plans to pay the firm a total of $457,889.

Sharman said he and his firm interviewed more than 20 witnesses and reviewed thousands of pages of documents before releasing his report on April 7. It concluded that Bentley abused his power to try to hide evidence of an alleged affair with his former political adviser, Rebekah Mason.

Bentley resigned from office three days after the report was released. The Judiciary Committee had started impeachment hearings on the morning of Bentley’s resignation, which also came five days after the Ethics Commission found probable cause that Bentley violated the ethics law and campaign finance law.

The Legislature initially paid Sharman’s firm $33,915 under an emergency contract. The Judiciary Committee set a $350,000 cap on legal fees after that. But Sharman’s firm has billed for an additional $73,974 above the cap, House of Representatives spokesman Clay Redden said.

Redden said that request would be heard by the Alabama Board of Adjustment, a four-member board set up to hear certain claims against the state. 

Redden said the House would not contest the billing.

Ross Garber 

The governor’s office hired Connecticut attorney Ross Garber of the firm Shipman & Goodwin, for the impeachment investigation. The governor’s office has paid Garber’s firm $137,182, according to the state Finance Department.

The Decatur Daily reported on the legal fees.

Go to Source

CDL – Social Engineering Fraud: What Law Firms (and Everyone) Should Know

by Canadian Defence Lawyers

June 22, 2017

Webinar

Social Engineering Fraud – the simple act of inducing a company’s employee to do or say something that they would not otherwise do or say – has had a devastating impact on many Canadian companies, and has sparked some heated disputes around the applicability of crime insurance to these types of frauds.  This presentation will address how fraudsters use Social Engineering Fraud to commit crimes against organizations, and how crime insurance may (or may not) respond.  The presenters will also offer some practical tips on how to avoid becoming a victim of this extremely effective fraud technique, with particular emphasis on how law firms are themselves targeted, and what steps firms can take to minimize the risk of loss.   This timely presentation is crucial for both insurance professionals and lawyers.

Presenters:

Chris McKibbin, Partner, Fidelity Practice Group, Blaney McMurtry LLP

Joshua Laycock, National Fidelity Product Manager, The Guarantee Company of North America

To register click HERE

Visit event’s website
http://www.cdlawyers.org/?page=15#a467

Go to Source

Trump’s nominee for FBI director scrubbed Russia connection from his law firm bio

WASHINGTON - DECEMBER 15:  Deputy U.S. Attorney General James B. Comey (L) speaks with assistant attorney general Christopher Wray (R) during a news conference at the Justice Department December 15, 2004 in Washington DC. Comey announced that America Online Inc. has entered into an agreement with the government to defer prosecution charges of aiding and abetting securities fraud in connection with transactions between AOL and PurchasePro.com.  (Photo by Mark Wilson/Getty Images)

James Comey and Christopher Wray in 2004

Christopher Wray, Donald Trump’s nominee to replace James Comey at the FBI, used to include this information in his law firm bio.

Donald Trump’s nominee to be the director of the FBI, Christopher Wray, represented an American energy executive in 2006 who was being criminally investigated by the Russian government.

The information apparently disappeared well before Wray was tapped to become FBI director. According to his firm, the decision to change the page was made in January. The name of the American energy executive and the company involved were not included in the information, and Wray was acting against the Russian government in this instance. The oddest thing about the edit is that it seems to be the only information removed from the site. 

Removing the information only serves to point up one feature of the firm where Wray currently works.

King and Spalding has worked closely in the energy sector in Russia, according to the firm’s website. The firm represented companies in deals with the Russian state-owned oil company Rosneft and Gazprom.
 

That would be the same Rosneft with which Rex Tillerson made a $500 billion deal. The Rosneft that supposedly offered a huge payout to Carter Page.  Oh, and Page was also an advisor at Gazprom. Gazprom also has connections to the Ukrainian party that hired Paul Manafort. 

It’s not unusual for large law firms to cross paths with a lot of players. What’s odd is that when it comes to the Trump regime, all those paths seem to cross in the same place.

Go to Source

Package holiday firms warn Brits who make fake sickness claims could be banned from hotels and even jailed

Britain’s biggest holiday companies and travel industry body ABTA have launched a campaign to fight crippling fake food poisoning claims.

Bosses from package firms including Thomas Cook, Tui, Jet2holidays, Monarch and Saga are calling on the Government to crackdown on the latest scam which is fleecing the Spanish hotel industry of more than £50 million a year.

The Stop Sickness Scams bid comes ahead of the great summer getaway to Spain, Portugal, Turkey and Greece.

Sunshine package giants Thomson, First Choice and Jet2holidays have already warned Brits they will be blacklisted if found guilty of bogus sickness claims.

Fake food poisoning claims have cost Spain’s hotel industry more than £50million

Yesterday Nick Longman, managing director of Tui – the parent company of Thomson and First Choice – said the flood of dodgy compensation claims from the UK had become ‘totally embarrassing’.

Mr Longman, who was the first to impose a ban on travel for fake tummy bug claimants, said: “A hotel will have customers from four or five markets of Tui and it will only be the British Tui customers who are complaining.”

Thomas Cook’s UK managing director, Chris Mottershead also warned that Britain’s compensation culture could sound the death knell for popular all-inclusive holidays which are at the heart of the bogus claims.

He said: “It’s a very serious situation because it has the effect of stopping all-inclusive holidays for the UK market.

“It has the potential of putting hoteliers out of business. They will stop British customers coming into their hotels.”

Both bosses have signed an open letter to Justice Secretary David Lidington calling for the Government to close a legal loophole that allows cowboy claims firms to charge sky-high fees for taking on holiday sickness claims.

Along with the heads of nine other leading tour operators, they are demanding a cap on fees which would stop rogue firms cashing in on bogus gastroenteritis claims dubbed the ‘new PPI’.

The firms warn that fake claims are fraud and they could be banned from hotels and even jailed

ABTA – the Association of British Travel Agents – is also urging Brits travelling to bogus holiday sickness hotspots like the Costas, Benidorm and Majorca to shop touts trawling beaches and resorts to drum up trade from gullible tourists.

Mark Tanzer, ABTA chief executive, said: “Holidaymakers need to know that whatever a claims firm might say, fake claims are fraud.

“Holidaymakers pursuing fake or exaggerated claims risk ending up in jail either in the UK or abroad.”

On its website the Foreign Office also warns British holidaymakers of legal action if they are found to have made false claims.

And the Spanish have vowed to crackdown on the fake claims culture with a zero tolerance policy that imposes a three-year jail sentence for those caught red handed.

Professor Jaime Campaner Munoz, the solicitor acting on behalf of the Federation of Majorcan Hotels, said: “We will be seeking convictions against anyone who is involved in these fraudulent claims.”

Spain has been the biggest target for out of control compensation chasers who have given Britain the ‘fake sick man of Europe’ tag.

The Costa del Sol, Costa Blanca, Costa Dorada and Benidorm have seen the highest number of scams as unscrupulous ‘no win – no fee’ firms cash in on the lucrative sickness claims industry.

As the law stands, holidaymakers just need a receipt for a tummy bug product to file a claim once they are back home.

In Benidorm hotel owners have asked chemists not to sell stomach upset cures to Brits unless they have a prescription amid fears receipts will be used for over-inflated illness claims.

Go to Source

More scrutiny for listed firms in new CMA rules

A board meeting. Board members must declare possibility of conflict of interest in their dealings with a company under the new rules. [Courtesy]

You will soon be able to interrogate the management of a company before you invest in it.

This will be made possible by a move by the Capital Markets Authority (CMA) to implement radical rules to increase transparency among listed firms.

The regulator has published a template where a company will declare its true financial state in a bid for the regulator and would-be investors to detect early warning signs and reduce conflict of interest where it may arise.

Interrogate reports

The law, which became effective on March 4 this year, means that all companies listed on the Nairobi Securities Exchange (NSE), will feed details into the template and post them on their websites.

“As required by the code, the template once duly filled and signed will be uploaded on the issuer’s website within four months after the end of the issuer’s financial year. Investors and the general public are encouraged to interrogate the reports to inform their engagement with the companies they invest in,” said CMA in a public notice yesterday. The new rules, especially put the board of directors as the people responsible for transparent and effective stewardship of companies and prohibit them from holding such positions in more than three public listed companies at any one time.

ALSO READ:

Capital markets yet to receive notice of National Bank takeover plan

It also sets an age limit for holding board positions at 70 years and the tenure of an independent board member of a cumulative term of nine years.

Board members also have to declare possibility of conflict of interest and they must not have been employed by the company in an executive capacity within the last three years if they are to serve on the board. This comes even as Parliament also seeks to amend the companies Act to shine more light on directors and scrutinise their relatives who do businesses with them.

Under the Companies Amendment Bill (2017) sponsored by Majority Leader Aden Duale, directors of companies will have to declare extended relations, including their in-laws, brothers and sisters, grand children as well as the spouses of all the these relatives who conduct businesses with their firms.

The bill also seeks to have directors declare any transactions done by a director with the company, the amount notwithstanding.

Go to Source

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sky Solar Holdings, Ltd. of Class Action Lawsuit and Upcoming Deadline – SKYS

NEW YORK, NY / ACCESSWIRE / June 20, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against Sky Solar Holdings, Ltd. (“Sky Solar” or the “Company”) (NASDAQ: SKYS) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 17-cv-04572, is on behalf of a class consisting of investors who purchased or otherwise acquired the American Depositary Shares (“ADSs”) of Sky Solar: (1) pursuant and/or traceable to Sky Solar’s false and misleading Registration Statement and Prospectus issued in connection with the Company’s initial public offering completed on or about November 18, 2014 (the “IPO” or the “Offering”); and/or (2) on the open market between November 14, 2014 and June 12, 2017, both dates inclusive, seeking to recover compensable damages caused by Defendants’ violations of the Securities Act of 1933 (“Securities Act”) and the Securities Exchange Act of 1934 (the “Exchange Act”).

If you are a shareholder who purchased Sky Solar securities, you have until August 15, 2017 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.

[Click here to join this class action]

Sky Solar Holdings, Ltd., an independent power producer, develops, owns, and operates solar parks worldwide. The Company develops projects and generates and sells electricity in the downstream solar market. The Company also sells solar energy systems, including pipeline and related engineering, construction, and procurement services, and is involved in building and transferring solar parks. In addition, Sky Solar provides operating and maintenance services for solar parks and sells solar modules.

On or about November 18, 2014, Sky Solar completed its IPO, issuing 6,353,750 ADSs and raising net proceeds of approximately $46.1 million.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Sky Solar’s Code of Business Conduct and Ethics, and the code’s enforcement by the Company’s Board of Directors, were inadequate to detect and/or deter misconduct by Sky Solar’s officers and directors; (ii) consequently, Sky Solar’s founder Weili Su (“Su”) was involved in undisclosed misconduct during his tenure at the Company; and (iii) as a result of the foregoing, Sky Solar’s public statements were materially false and misleading at all relevant times.

On June 6, 2017, shortly before the markets closed, Sky Solar announced that Su would “no longer serve as the Company’s Chief Executive Officer, or as director, officer, manager, legal representative or in any other management position of the Company’s subsidiaries or any other consolidated entities.”

On this news, the Company’s ADS price fell $0.02, or 1.06%, to close at $1.87 on June 7, 2017, the following trading day.

On June 13, 2017, Sky Solar revealed that the Company’s Management Committee plans to recommend that the board of directors form a committee to investigate Su’s conduct during his tenure as Sky Solar’s CEO.

Following this news, Sky’s ADSs temporarily ceased trading. When trading resumed, on June 15, 2017, Sky’s ADS price fell $0.19, or 10.35%, to close at $1.66 on June 15, 2017.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

SOURCE: Pomerantz LLP

ReleaseID: 466332

NEW YORK, NY / ACCESSWIRE / June 20, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against Sky Solar Holdings, Ltd. (“Sky Solar” or the “Company”) (NASDAQ: SKYS) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 17-cv-04572, is on behalf of a class consisting of investors who purchased or otherwise acquired the American Depositary Shares (“ADSs”) of Sky Solar: (1) pursuant and/or traceable to Sky Solar’s false and misleading Registration Statement and Prospectus issued in connection with the Company’s initial public offering completed on or about November 18, 2014 (the “IPO” or the “Offering”); and/or (2) on the open market between November 14, 2014 and June 12, 2017, both dates inclusive, seeking to recover compensable damages caused by Defendants’ violations of the Securities Act of 1933 (“Securities Act”) and the Securities Exchange Act of 1934 (the “Exchange Act”).

If you are a shareholder who purchased Sky Solar securities, you have until August 15, 2017 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.

[Click here to join this class action]

Sky Solar Holdings, Ltd., an independent power producer, develops, owns, and operates solar parks worldwide. The Company develops projects and generates and sells electricity in the downstream solar market. The Company also sells solar energy systems, including pipeline and related engineering, construction, and procurement services, and is involved in building and transferring solar parks. In addition, Sky Solar provides operating and maintenance services for solar parks and sells solar modules.

On or about November 18, 2014, Sky Solar completed its IPO, issuing 6,353,750 ADSs and raising net proceeds of approximately $46.1 million.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Sky Solar’s Code of Business Conduct and Ethics, and the code’s enforcement by the Company’s Board of Directors, were inadequate to detect and/or deter misconduct by Sky Solar’s officers and directors; (ii) consequently, Sky Solar’s founder Weili Su (“Su”) was involved in undisclosed misconduct during his tenure at the Company; and (iii) as a result of the foregoing, Sky Solar’s public statements were materially false and misleading at all relevant times.

On June 6, 2017, shortly before the markets closed, Sky Solar announced that Su would “no longer serve as the Company’s Chief Executive Officer, or as director, officer, manager, legal representative or in any other management position of the Company’s subsidiaries or any other consolidated entities.”

On this news, the Company’s ADS price fell $0.02, or 1.06%, to close at $1.87 on June 7, 2017, the following trading day.

On June 13, 2017, Sky Solar revealed that the Company’s Management Committee plans to recommend that the board of directors form a committee to investigate Su’s conduct during his tenure as Sky Solar’s CEO.

Following this news, Sky’s ADSs temporarily ceased trading. When trading resumed, on June 15, 2017, Sky’s ADS price fell $0.19, or 10.35%, to close at $1.66 on June 15, 2017.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

SOURCE: Pomerantz LLP

ReleaseID: 466332

Source URL: http://marketersmedia.com/shareholder-alert-pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-sky-solar-holdings-ltd-of-class-action-lawsuit-and-upcoming-deadline-skys/209796

Source: AccessWire

Release ID: 209796

Go to Source

RERA impact: Small developers look to partner with larger firms to revive stalled projects

A prolonged slowdown and the implementation of the new real estate law are forcing several mid to small size residential developers to seek partnerships with larger developers to help revive their projects stalled by funds shortage and regulatory hurdles. 

Many local builders in Maharashtra, where the new Real Estate (Regulations and Development) Act (RERA) has been notified and a regulatory body has been formed, have approached large developers with deep pockets to take over their stalled projects. Some others are seeking partnerships for new projects which have not taken off. 

In April, Bengaluru-based Ozone Group revived Vijay Raheja Group’s “The Gateway” luxury project at Andheri. The project with a development potential of 120,000 sq. ft, was stuck half way through due to financial reasons. Ozone invested in the project and is currently marketing it, said a person close to the development. 

Aditya Birla Real Estate Fund, an investor in the project, confirmed that ‘The Gateway’ is currently being co-branded by Vijay Raheja and Ozone Group. A spokesperson for Ozone Group declined to comment.

Ozone Group, which is planning to ramp up its business in Mumbai, is evaluating seven to eight such projects by local builders. “After RERA comes in, there will be a lot of opportunity at the project level. Either the builder does not have the wherewithal to sell and construct, or sometimes, the projects are stuck for want of funds,” said the person mentioned above on condition of anonymity.

Navi Mumbai-based Terraform Realty Ltd is actively looking to partner with large developers to monetize some of its land assets or jointly construct five of its ongoing projects which are at various stages of development. 

“We are looking to join hands with larger groups with better execution capability. While we have the wherewithal for holding land and taking care of the land asset per se, the development will be done by someone else,” said Santosh Santholia, vice-president, Terraform Realty. The company has signed memoranda of understanding with other bigger developers to start two of its projects, he said, but did not disclose names of the builders.

Large builders like Godrej Properties Ltd, Oberoi Realty Ltd and Hiranandani Communities said many local builders are looking to sell their entire project or seeking partnerships for new ones. 

“There has certainly been higher levels of engagement with local players as compared to last year and we expect to see this phenomenon further accelerate in the near future aided by consolidation and exits happening in the market,” said Mohit Malhotra, managing director and chief executive officer (CEO) , Godrej Properties Ltd. 

Subscribe to Our Newsletter »

Earlier this year, the company entered into a development management agreement with Shivam Realty to develop a housing project at Kandivali East in Mumbai.

“We are engaging with developers across the spectrum to either partner or purchase their land parcels,” he said.

Hiranandani Communities is also looking at the joint development model for the first time given that there are rising opportunities for distressed sale in the market.

First Published: Wed, Jun 21 2017. 01 18 AM IST

Go to Source

Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synchronoss Technologies, Inc. of Class Action Lawsuit and Upcoming Deadline – SNCR

NEW YORK, NY / ACCESSWIRE / June 20, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against Synchronoss Technologies, Inc. (“Synchronoss” or the “Company”) (NASDAQ: SNCR) and certain of its officers. The class action, filed in United States District Court, District of New Jersey, and docketed under 17-cv-04147, is on behalf of a class consisting of investors who purchased or otherwise acquired Synchronoss securities, seeking to recover compensable damages caused by defendants’ violations of the Securities Exchange Act of 1934.

If you are a shareholder who purchased Synchronoss securities between December 6, 2016 and April 26, 2017, both dates inclusive, you have until June 30, 2017 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll free, ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.

[Click here to join this class action]

Synchronoss provides mobile solutions for Service Providers and Enterprise through scalable software solutions and platforms. The Company purports to simplify the creation and management of customer and employee experiences associated with identity, cloud, messaging, applied analytics, and secure mobility.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Intralinks was underperforming; (ii) as such, the Company’s guidance was overstated; and (iii) as a result of the foregoing, Synchronoss’s public statements were materially false and misleading at all relevant times.

On April 27, 2017, the Company issued a press release entitled “Synchronoss Announces Management Changes; Company Issues Preliminary First Quarter 2017 Results.” Therein, the Company disclosed that it expected “total revenue for the first quarter of 2017 to be $13 million to $14 million less than the company’s previously announced guidance” and that it expected operating margins of 8% to 10% which was also less than previously announced guidance. The Company stated that it was “disappointed with [its] Q1 performance in this first quarter following our acquisition of Intralinks.” The Company further disclosed that its Chief Executive Officer (“CEO”), Ronald Hovsepian, and its Chief Financial Officer (“CFO”), John Frederick were leaving the Company.

On this news, the Company’s stock price fell $11.33 per share, or 46%, to close at $13.29 per share on April 27, 2017, on unusually heavy trading volume.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

SOURCE: Pomerantz LLP


Go to Source

Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Intra-Cellular Therapies, Inc. of Class Action Lawsuit and Upcoming Deadline – ITCI

NEW YORK, NY / ACCESSWIRE / June 20, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against Intra-Cellular Therapies, Inc. (“Intra-Cellular” or the “Company”) (NASDAQ: ITCI) and certain of its officers. The class action, filed in United States District Court, Eastern District of New York, and docketed under 17-cv-03197, is on behalf of a class consisting of investors who purchased or otherwise acquired Intra-Cellular securities, seeking to recover compensable damages caused by defendants’ violations of the Securities Exchange Act of 1934.

If you are a shareholder who purchased Intra-Cellular securities between August 12, 2014 and April 28, 2017, both dates inclusive, you have until July 11, 2017 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll free, ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.

[Click here to join this class action]

Intra-Cellular Therapies, Inc. is a biopharmaceutical company that is focused on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system, or CNS. The Company’s lead drug candidate, ITI-007 also known as lumateperone, is supposed to treat schizophrenia, behavioral disturbances in dementia, bipolar disorder and other neuropsychiatric and neurological disorders.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) the findings related to toxicity observed in animals treated with lumateperone (ITI-007); (ii) these findings posed an additional safety concern regarding lumateperone; (iii) as a result of the foregoing, Intra-Cellular’s public statements were materially false and misleading at all relevant times.

On May 1, 2017, before the market opened, the Company issued a press release entitled, ?Intra-Cellular Therapies Provides Corporate Update on Schizophrenia Program? which revealed findings of toxicity in animals treated with lumateperone.

On this news, Intra-Cellular’s share price fell $3.33, or over 24%, to close at $10.49 on May 1, 2017.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

SOURCE: Pomerantz LLP


Go to Source